Rovi Reduces Capital With The Redemption Of Own Shares

T-Reuters

Jun 16, 2022

Laboratorios Farmaceuticos ROVI SA :Has Resolved To Proceed With Execution Of Decrease Of Share Capital By Eur 123,168.48 Through Redemption Of 2,052,808 Treasury Shares, Each Of Them With A Nominal Value Of Eur 0.06.Purpose Of Capital Reduction Is Amortization Of Treasury Stock.Share Capital Decrease Does Not Entail A Return Of Capital Contributions To Shareholders.Share Capital Decrease Will Be Carried Out Against Share Capital And No Reserve Will Be Created.Afterwards, Rovi Will Request Exclusion From Trading Of Redeemed Shares On Stock Exchanges Of Barcelona, Bilbao, Madrid And Valencia.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2243972924"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2243972924\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2243972924?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-06-16 14:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2243972924","market":"hk","top_or_hot":-1,"title":"Rovi Reduces Capital With The Redemption Of Own Shares","media":"T-Reuters","content":"<html><body><p>Laboratorios Farmaceuticos ROVI SA <rovi.mc>:Has Resolved To Proceed With Execution Of Decrease Of Share Capital By Eur 123,168.48 Through Redemption Of 2,052,808 Treasury Shares, Each Of Them With A Nominal Value Of Eur 0.06.Purpose Of Capital Reduction Is Amortization Of Treasury Stock.Share Capital Decrease Does Not Entail A Return Of Capital Contributions To Shareholders.Share Capital Decrease Will Be Carried Out Against Share Capital And No Reserve Will Be Created.Afterwards, Rovi Will Request Exclusion From Trading Of Redeemed Shares On Stock Exchanges Of Barcelona, Bilbao, Madrid And Valencia.</rovi.mc></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rovi Reduces Capital With The Redemption Of Own Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRovi Reduces Capital With The Redemption Of Own Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2022-06-16 14:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Laboratorios Farmaceuticos ROVI SA <rovi.mc>:Has Resolved To Proceed With Execution Of Decrease Of Share Capital By Eur 123,168.48 Through Redemption Of 2,052,808 Treasury Shares, Each Of Them With A Nominal Value Of Eur 0.06.Purpose Of Capital Reduction Is Amortization Of Treasury Stock.Share Capital Decrease Does Not Entail A Return Of Capital Contributions To Shareholders.Share Capital Decrease Will Be Carried Out Against Share Capital And No Reserve Will Be Created.Afterwards, Rovi Will Request Exclusion From Trading Of Redeemed Shares On Stock Exchanges Of Barcelona, Bilbao, Madrid And Valencia.</rovi.mc></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2243972924","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2243972924","pubTimestamp":1655360087,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Laboratorios Farmaceuticos ROVI SA :Has Resolved To Proceed With Execution Of Decrease Of Share Capi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Rovi通过赎回自己的股票来减少资本","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ROVI":0.9},"content_text":"Laboratorios Farmaceuticos ROVI SA :Has Resolved To Proceed With Execution Of Decrease Of Share Capital By Eur 123,168.48 Through Redemption Of 2,052,808 Treasury Shares, Each Of Them With A Nominal Value Of Eur 0.06.Purpose Of Capital Reduction Is Amortization Of Treasury Stock.Share Capital Decrease Does Not Entail A Return Of Capital Contributions To Shareholders.Share Capital Decrease Will Be Carried Out Against Share Capital And No Reserve Will Be Created.Afterwards, Rovi Will Request Exclusion From Trading Of Redeemed Shares On Stock Exchanges Of Barcelona, Bilbao, Madrid And Valencia.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}